Aurora Spine Corporation (ASG.V)
CAD 0.43
(1.18%)
CAD 0.43
(1.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 14.52 Million USD | -2.4% |
| 2022 | 14.87 Million USD | 41.09% |
| 2021 | 10.54 Million USD | 21.97% |
| 2020 | 8.64 Million USD | -22.48% |
| 2019 | 11.15 Million USD | 28.45% |
| 2018 | 8.68 Million USD | 44.97% |
| 2017 | 5.98 Million USD | -11.36% |
| 2016 | 6.75 Million USD | 37.87% |
| 2015 | 4.9 Million USD | 89.17% |
| 2014 | 2.59 Million USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 4.01 Million USD | -0.75% |
| 2024 Q2 | 4.07 Million USD | 1.64% |
| 2024 Q3 | 4.76 Million USD | 16.85% |
| 2023 Q2 | 3.56 Million USD | 20.64% |
| 2023 Q4 | 4.04 Million USD | 2.4% |
| 2023 Q3 | 3.94 Million USD | 10.68% |
| 2023 FY | 14.52 Million USD | -2.4% |
| 2023 Q1 | 2.95 Million USD | -18.05% |
| 2022 Q2 | 4.06 Million USD | 14.5% |
| 2022 Q1 | 3.55 Million USD | 19.8% |
| 2022 Q4 | 3.6 Million USD | -1.07% |
| 2022 FY | 14.87 Million USD | 41.09% |
| 2022 Q3 | 3.64 Million USD | -10.29% |
| 2021 FY | 10.54 Million USD | 21.97% |
| 2021 Q1 | 2.26 Million USD | -7.19% |
| 2021 Q3 | 2.89 Million USD | 19.26% |
| 2021 Q4 | 2.96 Million USD | 2.5% |
| 2021 Q2 | 2.42 Million USD | 7.23% |
| 2020 Q2 | 1.58 Million USD | -30.05% |
| 2020 Q4 | 2.43 Million USD | 2.89% |
| 2020 FY | 8.64 Million USD | -22.48% |
| 2020 Q3 | 2.36 Million USD | 49.87% |
| 2020 Q1 | 2.25 Million USD | -14.18% |
| 2019 Q2 | 3.26 Million USD | 19.46% |
| 2019 FY | 11.15 Million USD | 28.45% |
| 2019 Q4 | 2.63 Million USD | 4.03% |
| 2019 Q3 | 2.53 Million USD | -22.38% |
| 2019 Q1 | 2.72 Million USD | 9.13% |
| 2018 Q4 | 2.5 Million USD | -6.54% |
| 2018 FY | 8.68 Million USD | 44.97% |
| 2018 Q1 | 1.5 Million USD | 11.36% |
| 2018 Q2 | 2 Million USD | 33.18% |
| 2018 Q3 | 2.67 Million USD | 33.66% |
| 2017 Q1 | 1.52 Million USD | -9.61% |
| 2017 FY | 5.98 Million USD | -11.36% |
| 2017 Q2 | 1.43 Million USD | -5.92% |
| 2017 Q4 | 1.34 Million USD | -19.49% |
| 2017 Q3 | 1.67 Million USD | 16.76% |
| 2016 Q1 | 1.54 Million USD | 3.6% |
| 2016 Q3 | 1.62 Million USD | -14.13% |
| 2016 Q4 | 1.68 Million USD | 3.87% |
| 2016 Q2 | 1.89 Million USD | 22.2% |
| 2016 FY | 6.75 Million USD | 37.87% |
| 2015 Q4 | 1.49 Million USD | 27.48% |
| 2015 Q3 | 1.17 Million USD | 25.57% |
| 2015 FY | 4.9 Million USD | 89.17% |
| 2015 Q2 | 934.14 Thousand USD | -28.04% |
| 2015 Q1 | 1.29 Million USD | -0.16% |
| 2014 Q1 | 284.66 Thousand USD | 0.0% |
| 2014 Q2 | 462.27 Thousand USD | 62.39% |
| 2014 Q3 | 543.42 Thousand USD | 17.56% |
| 2014 Q4 | 1.3 Million USD | 139.26% |
| 2014 FY | 2.59 Million USD | 0.0% |
| 2013 Q3 | 73.9 Thousand USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand CAD | -3498.327% |
| Therma Bright Inc. | 23.89 Thousand CAD | -60657.504% |
| Theralase Technologies Inc. | 1.07 Million CAD | -1256.661% |
| VentriPoint Diagnostics Ltd. | 49.18 Thousand CAD | -29423.282% |